This review focuses on the recent technological advances in quantitative sodium ( 23 Na) MRI to provide a noninvasive measure of tissue viability for use in clinical studies of patients with kidney disease.
INTRODUCTION
Hydrogen ( 1 H)-based magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) is widely used to provide invaluable information on structure and function of the human body, but importantly other naturally abundant nuclei in biological tissue, such as sodium ( 23 Na), can also be imaged. 23 Na is the second most abundant NMR sensitive nucleus in the human body. 23 Na imaging has the potential to provide complementary quantitative measures compared with 1 H MR, however, its use has been limited because of the far lower sensitivity of 23 Na MRI in the body. Despite the demonstration of sodium MRI in the early 1980s [1, 2] , it has only been in recent years that its use has been rediscovered, with the availability of high and ultra-high field (3 and 7 T) MR scanners and advances in MR technology in terms of radiofrequency coil and pulse sequence design. Applications of 23 Na MRI have been shown in the brain, heart, and cartilage, as well as in the skin, muscle, and kidney, which will be the focus of this review.
TECHNICAL ASPECTS OF SODIUM MRI
In-vivo 23 Na MRI is challenging compared with 1 H MRI, because of its low sensitivity, which is of the order of 3000-20 000 times less than 1 H MRI (organdependent). This results from the lower gyromagnetic ratio (g) of 23 Na compared with 1 H (g of 23 Na is 11.26 MHz/T compared with 42.58 MHz/T), the quantum mechanical property of spin of the 23 Na nucleus taking a value of (3/2) compared with (1/2) for 1 H, and the low natural abundance of 23 Na in the biological tissues. Further, the (3/2) spin results in sodium having a quadrupolar moment, meaning that the MR signal from sodium decays significantly faster than for protons, resulting in a short longitudinal (T 1 ) and rapid bi-exponential transverse (T 2 ) signal decay with fast (T 2f , 60% of signal) and slow (T 2s , 40% of signal) components.
For the implementation of 23 Na MRI, the MR scanner needs to be equipped with specialised transmit and receive radiofrequency coils tuned to the resonance frequency of sodium nuclei at the respective field strength, but this is now possible on most MR scanners used for research purposes. In addition, scanning hardware and pulse sequences need to image faster for 23 Na MRI compared with 1 H MRI, because of the rapid decay of the 23 Na signal. To overcome the low sensitivity of 23 Na MRI, signal-tonoise ratio (SNR) is gained by imaging at lower spatial resolution and signal averaging for a number of minutes compared with seconds typically used for 1 H MRI. The linear proportionality of the 23 Na NMR signal to the spin density then allows for the absolute quantification of the tissue sodium concentration (TSC) on the basis of a known concentration reference phantom placed within the scanner.
There have been a number of recent comprehensive reviews of sodium imaging [3] [4] [5] [6] , which describe the challenges of 23 Na MR, advances in scanning hardware and imaging techniques, and provide an overview of applications of 23 Na MRI. This review focuses on the potential role of 23 Na MRI in nephrology, including imaging of the kidneys, and the use of sodium MRI to study sodium stored in the muscle and in the skin, suggested to be of relevance in hypertension and chronic kidney disease (CKD).
BIOLOGICAL PROCESSES ASSESSABLE BY SODIUM MRI
Sodium is a vital electrolyte in the body and plays several roles including maintaining the volume of blood and fluid and regulating pH within the body. At a cellular level, the concentration of sodium within and outside cells is carefully maintained by the sodium-potassium Na þ /K þ -ATPase pump, with a large difference in concentration between intracellular (10-15 mM) and extracellular sodium (140-150 mM). This produces a substantial electrochemical gradient, essential for transmitting nerve pulses and pumping ions throughout the cells. This gradient is very sensitive to cell health, and changes in this sodium gradient will be reflected in cell integrity. Typically, an increase of TSC indicates a loss of tissue viability and is associated with an increase of intracellular sodium because of the loss of the integrity of the cell, and also with an increase of extracellular volume whenever cells are dying. Thus, 23 Na MRI could provide direct biochemical markers for cell integrity and tissue viability, or for following changes in tissue viability upon treatment.
One of the main tasks of the human kidneys is to maintain the homeostasis of the body's fluid and electrolyte balance by filtration of the plasma and excretion of the end products. The regulation of extracellular sodium and water balance in the kidney is of particular importance, as this leads to an increasing sodium concentration gradient from the renal cortex to the medulla. A high-sodium concentration in the medulla is crucial for the final concentration of the urine by reabsorption of water. The ability to image the TSC and monitor any changes in the corticomedullary sodium concentration gradient (CMSG) in vivo will potentially increase our knowledge of renal physiology and allow the monitoring of changes during a variety of kidney diseases.
Recent evidence showing that sodium is stored in the skin and that interstitial electrolyte balance is achieved by renal and extra-renal mechanisms has identified a need for 23 Na MRI to assess skin interstitial sodium in vivo under a variety of experimental conditions to evaluate the role of skin sodium in the pathogenesis of hypertension and cardiovascular disease [7 && ]. Studies to-date indicate that these tissue sodium levels are not reliably measured by sampling blood or interstitial fluid. Recent evidence from chemical analysis of tissue electrolyte and water composition has shown that body sodium content does not always readily equilibrate with water, and cannot be exclusively controlled by the renal mechanisms [8] . In muscle,
KEY POINTS
23 Na MRI is the only noninvasive imaging technique that allows the absolute spatial quantification of tissue sodium concentration (TSC). 23 Na MRI of the kidney has the sensitivity to measure the corticomedullary sodium gradient (CMSG), demonstrating a reduction in the CMSG in kidney disease and transplanted kidneys. 23 Na MRI has demonstrated an increase in skin and muscle sodium storage with advancing age, and increased tissue sodium content in hypertensive patients. 23 Na MRI is currently a research technique, but with future advances, 23 Na MRI has the potential to become a noninvasive renal biomarker and a measure of tissue sodium storage for clinical studies.
sodium changes have been linked to several disease states, including diabetes mellitus, hypertension, and cardiovascular risk. It has therefore been suggested that the pathophysiological process of skin and muscle sodium storage is of relevance for health and disease, with sodium accumulation in the extracellular space closely associated with essential hypertension [9] .
SODIUM MRI OF THE KIDNEY: NORMAL RANGE IN HEALTHY INDIVIDUALS AND CHANGES IN KIDNEY DISEASE
Sodium MRI of the kidney was first performed in 1988 at 1.5 T [10] , yielding low resolution sodium images. It was not until 2006, as MR hardware and imaging techniques developed, that sodium imaging of the kidney was performed at 3 T [11] , producing the first maps of sodium distribution in the kidney and a qualitative measure of the CMSG.
NORMAL RANGE IN HEALTHY INDIVIDUALS
Quantitative measurement of the sodium concentration in the kidney was first achieved by Haneder et al. [12] in 2011, using reference NaCl solutions of known concentrations positioned alongside the patient for calibration of the kidney sodium images. Using this method, the effect of water loading on kidney 23 Na concentration was measured in healthy volunteers who abstained from water intake for six hours prior to their first 23 Na MRI and subsequently ingested 1 l of water 30 min prior to their second 23 Na MRI. Water loading caused a reduction in the sodium concentration within the kidney, with a decrease from 63.5 AE 9.3 to 48.6 AE 5.3 mmol/l in the cortex and 108.0 AE 10.9 to 81.9 AE 10.1 mmol/l in the medulla, but the CMSG was not affected. They then advanced these 23 Na MRI measures by assessing the corticomedullary gradient [13] using a higher spatial resolution isotropic voxels and investigated the use of the cerebrospinal fluid (CSF) 23 Na signal as an internal reference. In 2014, Haneder et al. [14] evaluated the feasibility of in-vivo 23 Na MRI of the corticomedullary gradient and measurement of 23 Na transverse relaxation times (T 2 Ã ) in human kidneys at ultra-high field (7 T), showing mean corticomedullary 23 Na SNR increased from the cortex (32.2 AE 5.6) towards the medullary pyramids (85.7 AE 16.0) and 23 Na T 2 Ã relaxation times differed statistically significantly (P < 0.001) between the cortex (17.9 AE 0.8 ms) and medulla (20.6 AE 1.0 ms).
Further studies were performed [15] to ascertain the normal range of corticomedullary sodium concentration in the healthy human kidney, with a mean sodium concentration in the cortex of 58 AE 17 mmol/l (range 27-63 mmol/l) and 99 AE 18 mmol/l (range 126-187 mmol/l) in the medulla. No significant correlation was found between the sodium concentration and age, sex, BMI, or glomerular filtration rate (GFR).
CHANGES IN KIDNEY DISEASE
Haneder et al. [16] performed two studies investigating the feasibility of using 23 Na MRI to measure changes in the sodium concentration in the kidney in disease. In the first study, they combined 23 Na MRI and functional 1 H MRI to measure damage in the kidney exposed to radiotherapy to treat gastric cancer, as reviewed by [5] and shown in Fig. 1 . Functional 1 H MRI revealed changes consistent with reduced cell density and tissue oxygenation and 23 Na MRI showed a partial loss of sodium corticomedullary concentration gradient in the upper pole of the kidneys exposed to radiation, confirming that loss of CMSG may be an early marker of kidney damage. They further demonstrated the ability of 23 Na MRI to detect changes in renal sodium content in vivo in a study of patients with central diabetes insipidus [17] by showing that both cortical and medullary sodium concentration decreased by a mean of 17.1 AE 1.1% following intranasal administration of 20 mg desmopressin.
In 2014, Moon et al. [18] performed 23 Na MRI of transplanted kidneys using a dual tuned coil capable of aquiring both proton and sodium images within the same scan session without the need to reposition the patient. This allowed 1 H and 23 Na images to be overlaid, providing the advantage of accurate segmentation of the medulla and cortex based on the high quality 1 H MRI images that could be applied to the corresponding 23 Na image. A significant reduction was seen in the sodium concentration in the transplanted kidneys, 153.5 AE 11.9 mM compared with the healthy controls, 192.2 AE 9.2 mM, and a reduction in the CMSG at 8.9 AE 1.5 mM/mm in the transplanted kidney and 10.5 AE 0.9 mM/mm in the healthy kidneys. However, there was no significant difference in sodium levels or CMSG between those transplanted kidneys with acute rejection versus normal function, though the sample size was small with only six patients.
Sodium imaging of the kidneys was also performed by Budjan et al. [19 1 H MRI have shown that muscle and skin can store sodium without water retention [20] , contrary to the previous opinion that an increase in sodium intake increases tissue water content. Muscle 23 Na MRI is typically performed using a dedicated knee coil to provide sodium images of the calf muscle, whereas assessment of skin sodium requires higher spatial resolution imaging. To achieve this, skin 23 Na MRI is typically performed on the calf muscle using customized radiofrequency surface coils to provide an in-plane spatial resolution that is less than 1 mm. Tubes of NaCl (10, 20, 30 , and 40 mmol/l) are used as calibration standards to linearly relate the 23 Na intensity to 23 Na concentration. Typically, a 1 H image is also collected to measure water content.
NORMAL RANGE IN HEALTHY INDIVIDUALS
In 2013, Kopp et al. [9] demonstrated the important finding that sodium concentrations can be quantified noninvasively in skin and skeletal muscles in humans with 23 Na MRI, and that when coupled with conventional 1 H MRI imaging, water content can be judged simultaneously. They observed an increase in sodium storage with advancing age, especially remarkable because salt-sensitivity in humans increases with age. Muscle sodium increase was less profound in women compared with men, and muscle sodium deposition was not accompanied by simultaneous water accumulation. In contrast to muscle, increasing sodium content in the skin was paralleled with increasing skin water content. Wang et al. [21 && ] recently investigated sex differences in the patterns of TSC in muscle and skin of the calf muscle using 23 Na MRI and showed that sodium content appears to be higher in skin than in muscle for men, however, women tend to have higher muscle sodium than skin sodium. Linz et al. [22] investigated the feasibility of high in-plane spatial resolution 23 Na MRI in skin at 7 T, demonstrating the benefits of 7 T to assess sodium stores compared with 3 T.
EFFECTS OF HAEMODIALYSIS
Sodium MRI has been used to study the removal of sodium from the skin and muscle during haemodialysis [23] , collecting 23 Na images of the calf before and after dialysis treatment. Skin and muscle sodium concentration increased with age in the FIGURE 1. A 56-year-old patient after adrenal stereotactic body radiotherapy. As an early effect of radiation therapy, the corticomedullary sodium gradient and sodium concentration are decreased in the left kidney. Left: color-coded sodium concentration (mmol/l). Right: T 2 -weighted morphological sequences. Middle: fusion of 23 Na and morphological sequences.
Top row: coronal orientation. Bottom row: axial orientation. Reproduced from [5] .
patients on haemodialysis, and also in controls. Younger patients on haemodialysis (<60 years) had similar skin and muscle sodium concentration as healthy controls before haemodialysis; after haemodialysis the sodium levels in muscle decreased (P < 0.01) and also tended to decrease in skin (P ¼ 0.1). Older haemodialysis patients (!60 years) initially had a higher TSC than controls, whereas postdialysis, a reduction in TSC was found such that the sodium concentration after haemodialysis was similar to controls in both skin (P ¼ 0.37) and muscle (P ¼ 0.62). In addition, this study compared the skin and muscle 23 Na MRI measures to the sodium eliminated by the dialyser, however, no correlation was found between sodium removal from plasma and skin or muscle sodium reduction measured by MRI. This study, therefore, showed that tissue stores of sodium can be mobilised during haemodialysis but that secondary clearance of sodium from tissues is less predictable than clearance from the plasma.
Further evidence of potential adverse effects of tissue sodium accumulation was provided by a study by Deger at al. [24 & ], which used 23 Na MRI to assess the mechanisms by which insulin resistance occurs in patients on maintenance haemodialysis compared with controls. All patients underwent hyperinsulinemic-euglycemic-euaminoacidemic clamp studies to measure disposal rates of glucose (GDR) and leucine (LDR) as well as 23 Na MRI of the calf to assess the skin and muscle sodium concentration. GDR and LDR levels were lower in haemodialysis patients compared with healthy controls, whereas the muscle sodium concentration was higher in haemodialysis patients. An inverse linear relationship was found between TSC in the muscle and GDR and LDR in haemodialysis patients, a trend not found in the healthy controls. There were no significant differences in skin sodium between dialysis patients and controls. This study, hence concluded that excessive muscle sodium may contribute to the development of insulin resistance in patients with end-stage renal disease on haemodialysis.
CHANGES IN HYPERTENSION
Although, it has long been recognised that high dietary sodium intake provokes hypertension in salt-sensitive individuals, 23 Na MRI has made it possible to study the role of tissue sodium storage in this complex pathophysiology. Kopp et al. [9] found that sodium storage in skin of the upper calf increased with age in hypertensive patients as well as controls. Sodium concentration in muscle increased with age in men but not women. When corrected for age, it was found that women with refractory hypertension had increased stored sodium in the skin, and men with refractory hypertension had increased sodium in muscle, compared with age-matched normotensive controls. Interestingly spironolactone treatment (in addition to another diuretic) in men with refractory hypertension was associated with lower muscle sodium concentration and a trend towards lower blood pressure (135 AE 16 versus 147 AE 19 mmHg; P ¼ 0.16) than men with refractory hypertension not receiving spironolactone. Further work is required to replicate these complex findings and elucidate the underlying mechanisms.
CHANGES IN CHRONIC KIDNEY DISEASE
Chronic kidney disease results in sodium retention and is linked with an increased risk of cardiovascular events, in part because of the high prevalence of left ventricular hypertrophy (LVH) in CKD. The pathogenesis of LVH in CKD is not fully understood and associations with dietary sodium intake have been inconsistent. A recent study found that in patients with CKD, high skin sodium content was associated with greater age, male sex, higher body mass index, higher 24 h systolic blood pressure and number of antihypertensives, urine albumin excretion, diabetes and cardiovascular disease. . In multivariable linear regression analysis, skin sodium content was a strong determinant of LVM, independent of 24 h systolic blood pressure and total body hydration.
CHANGES IN ACUTE KIDNEY INJURY
Acute kidney injury (AKI) is frequently associated with accumulation of extracellular sodium and water but is has not previously been possible to quantitate this accurately. In a recent work, Hammon et al. [26 && ] assessed skin and muscle 23 Na MRI in in seven patients with AKI, peripheral oedema, and weight gain. Before dialysis, patients with AKI evidenced higher calf muscle and skin sodium concentration than age-matched controls (Fig. 2) . However, there was no reduction in skin and muscle sodium or water content after four to five cycles of haemodialysis despite this achieving a mean total ultrafiltration volume of 8.36 l. These observations are in contrast to those in patients receiving chronic haemodialysis and others with heart failure. Limitations of this study include the small number of participants and variation in the haemodialysis delivered. The failure to reduce tissue sodium with acute haemodialysis in the setting of AKI, may be because of the more severe sodium accumulation in this setting and the unstable condition of patients
